Anodyne® Therapy is clinically proven and is now offered in nearly
6,000 medical facilities and 35 countries worldwide

Medical conditions and pain caused by circulatory problems can be some of the most frustrating conditions you treat. And this is where Anodyne Therapy (Monochromatic Infrared Photo-Thermal Energy or MIRE™) has been clinically proven to help. Increasing circulation (as measured by a sophisticated instrument called a Moor Scanning Laser Doppler images below) can help reduce pain and inflammation and improve your patients’ quality of life. And, Anodyne Therapy, when used adjunctively with a personalized physical therapy program, may help relieve pain that has not responded to other medical interventions.

To obtain a FREE Information Packet or
to find treatment locations for your patients, please Contact Us

Research

Studies

13 Studies Published in Peer-Reviewed Journals involving over 4,500 subjects.

Increased Circulation

Circulation increases were measured by a Moor Scanning Laser Doppler after a 20 - 30 minute Anodyne treatment. Brighter areas in the images below indicate more circulation.

Before Treatment

After Anodyne Treatment

heel2

heel1

Heel

Up to 3200% increase

back2

back1

Lower Back

Up to 1300% increase

elbow1

elbow2

Elbow

Up to 1300% increase

knee2

knee1

Knee

Up to 2000% increase

baseline
Baseline

 

400% Increase

 

MIRE

MIRE
Placebo
(Warmth)

40% Increase

 

 

Foot – Foot on left treated with Anodyne (MIRE™) showed a 400% increase in circulation while foot on right treated with a placebo heat treatment showed only a 40% increase in circulation.

Duration of Circulation Increase vs. Heating Pad


Pre Scan

 

Delayed Post Scan

Pre Scan Anodyne

4 hours after >> Anodyne Therapy

Post Scan Anodyne

FLUX: 124

 

FLUX: 328
164% increase

Pre Scan

 

Delayed Post Scan

Pre Scan Heat

2 hours after >> Heating Pad

Post Scan Heat

FLUX: 158

 

FLUX: 87
45% decrease

CompetitiveInfo

Click here to learn more about how Anodyne compares to competitive systems.

Pain Reduction Data

Data on File Comparing Anodyne Therapy Pain Relief to the Pain Relief of Historical Placebo Controls in 20 Pain Studies

Anodyne vs. Placebo

Pain Study #1

Journal:

Diabetes Care, Volume 27(1), January 2004.

Study Site(s):

Joslin Center for Diabetes at Morton Plant Hospital

Number of Subjects:

27 (All Diabetic)

Study Design:

Prospective, Randomized, Double Blind, Placebo Controlled

Protocol Used:

All subjects in the study had chronic pain in the lower extremities. Subjects initially received treatment with active therapy pads on one limb and sham pads on the other limb 3 times per week for 40 minutes each vist for 2 weeks (6 treatments). This was followed by six active treatments of the same duration administered to both limbs duing the following 2 weeks.

Pain Endpoint:

Numeric Visual Analog Scale from 0 – 10 (10 being the worst pain)

Results :

Group

VAS Baseline

After 6 MIRE Treatments

After12 MIRE
Treatments

P Value

1 (N=18)

4.2 + 2.3

3.2 + 1.9

2.3 + 1.7

<0.0001

2* (N=9)

4.2 + 3.9

2.6 + 2.3

2.0 + 2.3

NS

* Patients more impaired

Conclusion:

The results of the study demonstrate that treatments with near-infrared photo energy delivered in the manner specified in the study protocol resulted in a significant reduction in lower extremity pain.

Pain Study #2

Journal:

Diabetes and Its Complications, Volume 20(2),2006.

Study Site(s):

Multiple Site

Number of Subjects:

2239 (1395 Diabetic; 844 Non-Diabetic)

Study Design:

Multiple Site Retrospective Chart Review based on Prospective, Repeated Measures Analysis

Protocol Used:

All subjects in the study had chronic pain in the lower extermities. The average treatment protocol was 3 x per week for 30-45 minutes for 5 weeks and included physical therapy interventions such as therapeutic exercise, neuromuscular re-education and/or gait training.

Pain Endpoint:

Numeric Visual Analog scale from 0 – 10 (10 being the worst pain)

Results :

Patients Reporting Significant Pain Pre and Post Treatment


Pre

Post

# Improved

% Improved

1563

33

1530

98%

Changes in Pain on 11 point VAS (0-10; 10 being the worst pain)


Pre

Post

# Points Improved

P-Value

% Improved

7.2 ± 2.2

2.4 ± 2.1

4.8 ± 2.4

<0.0001

67%

Conclusion:

MIRE treatments are associated with a reduction in pain, even in patients with lower extremity pain levels between 8-10 on a 0-10 point scale.

Pain Study #3

Journal:

Physical and Occupational Therapy in Geriatrics, Volume 24(2), 2006.

Study Site(s):

Genesis Medical Center (Davenport, IA), Premier PT (Evergreen Park, IL, Orland Park, IL and Hinsdale, IL), Westside Retirement Village (Indianapolis, IN), Sonoma Valley Hospital (Sonoma, CA), Helmwood Healthcare (Elizabethtown, KY)

Number of Subjects:

272 (128 Diabetic, 144 Non-Diabetic)

Study Design:

This was a retrospective Chart Review in seven facilities and was based on Prospective, Repeated Measures Analysis.

Protocol Used:

All subjects in the study had chronic pain in the extremities. The therapy intervention included Anodyne Therapy for pain and circulation and physical therapy interventions such as therapeutic exercise, neuromuscular re-education and/or gait training 3 x per week for an average of 6 weeks.

Pain Endpoint:

Numeric Visual Analog scale from 0 – 10 (10 being the worst pain)

Results :

Patient Demographics (Pre-Treatment)

 

Total

Patients

272

Male

135

Female

137

Agea

69 ± 12.3

Mean Number of Treatments

18 ± 10.2

Treatment Time (in minutes)

34.2 ± 9.4

Pain Pre and Post Treatment Results


All Patients (Pain > 4)

(n = 257)

VAS Pre-Treatment

7.7 ± 1.2

VAS Post-Treatment

4.8a ± 2.2

VAS Decreases

2.9 ± 2.2

% Pain Reduction

38%

Horrible to Excruciating Pain (VAS 8.5-10)

(n = 37)

VAS Pre-Treatment

9.4 ± 0.5

VAS Post-Treatment

4.8a ± 2.7

VAS Decreases

4.6 ± 2.9

% Pain Reduction

49%

Distressing Pain (VAS 6.5-8)

(n = 189)

VAS Pre-Treatment

7.8 ± 0.4

VAS Post-Treatment

5.0a ± 1.9

VAS Decreases

2.8 ± 1.9

% Pain Reduction

36%

Discomforting Pain (VAS 4-6)

(n = 31)

VAS Pre-Treatment

5.3 ± 0.9

VAS Post-Treatment

3.5a ± 2.5

VAS Decreases

1.8 ± 2.4

% Pain Reduction

34%

a = Values expressed as mean ± SD; All post treatment measures are P<0.0001 vs. Pretreatment

Conclusion:

Use of MIRE in combination with other physical therapy interventions is associated with reduced lower extremity pain.

Pain Study #4

Journal:

Age and Ageing, Volume 35(1), 2006.

Study Site(s):

Multiple Sites

Number of Subjects:

252 (All Diabetic)

Study Design:

Retrospective Chart Review and Patient Questionnaire

Protocol Used:

All subjects in the study had chronic pain in the lower extremities. The initial therapy intervention included Anodyne Therapy for pain and circulation and physical therapy interventions such as therapeutic exercise, neuromuscular re-education and/or gait training. Patients then used an Anodyne Therapy System at home for an average of 8 months after the initial treatment in a clinical setting.

Pain Endpoint:

Numeric Visual Analog scale from 0 – 10 (10 being the worst pain)

Results :

Pain Reduction Based on Average Number of Months Using MIRE

 

1-3

3-6

6-9

9-12

12+

# of Patients

36

33

22

94

67

Ave. Months after MIRE Clinical Treatment

1.2

4.0

6.7

10.1

13.3

Mean Age

75

74

76

76

76

Male/Female

23/14

20/13

9/13

44/50

40/27

% of Patients Reporting Reduction in Pain

94%

80%

91%

85%

91%

Conclusion:

The medical records indicated that 220 out of 252 patients (87%, p< 0.0001) obtained substantial reduction in lower extremity pain. When patients have continuing access to MIRE in their homes following clinical treatment, there is a significant reduction in pain.

Pain Study #5


Journal):

Practical Pain Management, Volume 7(6), 2007.

Study Site(s):

Multiple Sites

Number of Subjects:

493 (248 Diabetic; 245 Non-Diabetic)

Study Design:

Multiple Site Retrospective Chart Review based on Prospective, Repeated Measures Analysis in combination with patient phone survey on prescription pain medication use.

Protocol Used:

All subjects in the study had chronic pain in the lower extremities. The average treatment protocol was 3 x per week for 30 minutes for a mean of 15-19 treatments and included physical therapy interventions such as therapeutic exercise, neuromuscular re-education and/or gait training.   After therapy was complete, 493 of 550 patients contacted agreed to provide answers to a health questionnaire.

Pain Endpoint:

Numeric Visual Analog scale from 0 – 10 (10 being the worst pain)

Results :

Mean pain reduction overall was 63.4%. 51.4% of patients who were on pain medications were able to reduce or eliminate their pain medications.
Pain Response to MIRE is Not Based on the
Use of Medication

 

No Pain Meds During MIRE

Decreased Pain Meds

No Change in Pain Meds

Changed Pain Meds

 

Group 1

Group 2

Group 3

Group 3

# of Patients

129

187

151

26

Male

66

72

63

13

Female

63

115

88

13

Age
(Range)

74
(53-94)

72
(44-90)

73
(46-93)

69
(54-94)

Duration of Pain (Months)a

41.5 ±
31.4

49.9 ± 32.9

54.3 ± 35.3

54.7 ± 38.8

Number of Treatmentsa

15 ± 9.2

15 ± 8.2

16 ± 9.1

19 ± 8.9

Initial Paina

6.7 ± 2.4

7.2 ± 1.9

6.7 ± 2.3

7.3 ± 1.9

Post Paina

2.4 ± 2.2b

2.5 ± 2.2b

2.6 ± 2.0b

2.6 ± 1.9b

Mean Pain Decreasea

4.3 ± 2.5b

4.7 ± 2.1b

4.2 ± 2.3b

4.7 ± 2.4b

% Pain Reduction

64.2%

65.3%

62.3%

64.4%

a = mean ± SD.  b = P<0.0001 vs. initial pain. Meds = medications.
Changed Pain Meds indicates either a different dose or a different medication, or both. 
Decreased Pain Meds indicates either a lowered dosage or a frequency or eliminated use of pain medications.

Conclusion:

MIRE, when administered as part of a physical therapy care plan prescribed by a physician, is associated with substantial lower extremity pain relief and the pain-relieving effects of Anodyne Therapy/MIRE appear to be independent of pain medication use.

To obtain a FREE Information Packet, please
Contact Us

Privacy / About DIC / Advertising With Us / Contact DIC

Entries (RSS News)
Add us to your favorite news reader

Copyright @ 1999-2007 Diabetes In Control, Inc.. All rights reserved.